Attempts to stratify melanoma therapy by tumoral PD-L1 expression, tumor mutational burden, pre-existing T cell infiltration, and an interferon γ signature are currently under consideration but have not yet been included as companion predictive diagnostics into clinical routine [44]. This evidence concerns the gene CD274 and neoplasm.